🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Alanna J. Church

Broad Institute

ORCID: 0000-0002-4835-5770

Also affiliated with Boston Children's Hospital, Harvard University, Dana-Farber/Boston Children's Cancer and Blood Disorders Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.400Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer

Nature Communications(2024)10.1038/s41467-024-49944-0
Top 46%
0.400DataRank
Top 46%8 citations

Hersh Gupta, Abigail Ward, Yvonne Li, Duong Doan, Alyaa Al‐Ibraheemi +28 more

Papers

Driven by 9 papers — median percentile 54. Top paper: “Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer”.

Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer

Nature Communications(2024)10.1038/s41467-024-49944-0
Top 46%
0.400DataRank
Top 46%8 citations

Hersh Gupta, Abigail Ward, Yvonne Li, Duong Doan, Alyaa Al‐Ibraheemi +28 more

Targeting EZH2 for the treatment of hepatosplenic T-cell lymphoma

Blood Advances(2020)10.1182/bloodadvances.2019001256
N/A
0DataRank · unranked
9 citations

Amy Saur Conway, Amanda L. Robichaud, Samuel Kitara, Alanna J. Church, Alyssa L. Kennedy +6 more

New molecular insights into the pathogenesis of lipoblastomas: clinicopathologic, immunohistochemical, and molecular analysis in pediatric cases

Human Pathology(2020)10.1016/j.humpath.2020.07.016
N/A
0DataRank · unranked
30 citations

Rita Alaggio, Sarangarajan Ranganathan, Lori Schmitt, Ivy John, Alanna J. Church +2 more

A phase II study of larotrectinib for children with newly diagnosed solid tumors and relapsed acute leukemias harboring TRK fusions: Children’s Oncology Group study ADVL1823.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps10560
N/A
0DataRank · unranked
2 citations

Kathleen Ludwig, Donald A. Barkauskas, Steven G. DuBois, Joan Ronan, Erin R. Rudzinski +10 more

Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3089
N/A
0DataRank · unranked
57 citations

Alyaa Al‐Ibraheemi, Duong Doan, Abigail Ward, Catherine Clinton, Juan Putra +11 more

A phase 1/2 study of bay 18953444 (Elimusertib) in pediatric patients with relapsed or refractory solid tumors: Initial report of the phase 1 results of PEPN2112.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e15131
N/A
0DataRank · unranked
9 citations

Julia Glade Bender, Charles G. Minard, Xiaowei Liu, Kristina Z. Denic, Joel M. Reid +8 more

Phase 2 study of larotrectinib in children with newly diagnosed infantile fibrosarcoma (IFS): Children’s Oncology Group (COG) ADVL1823 cohort A.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10008
N/A
0DataRank · unranked
5 citations

Kathleen Ludwig, David Hall, Donald A. Barkauskas, Stephan D. Voss, Steven G. DuBois +12 more

ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs

Cancer Research(2024)10.1158/0008-5472.can-23-2115
N/A
0DataRank · unranked
10 citations

Vijaya S.R. Kola, Joseph A. Kerfoot, Madeleine L. Taddei, Alyaa Al‐Ibraheemi, Yi-Hsuan Hsieh +5 more

Standardized evidence-based approach for assessment of oncogenic and clinical significance of NTRK fusions

Cancer Genetics(2022)10.1016/j.cancergen.2022.03.001
N/A
0DataRank · unranked
10 citations

Alanna J. Church, Shruti Rao, Arpad Danos, Larissa V. Furtado, Theodore W. Laetsch +11 more